Dr Nicholas Wickham trained in medicine at Cambridge and undertook advanced training in clinical and laboratory haematology at London’s Royal Postgraduate Medical School, Hammersmith Hospital, St Georges Hospital Medical School and the Royal Marsden Hospitals. During this time, he also worked as a research assistant at the Physiological Laboratory in Cambridge, investigating the properties of artificial fluorocarbon blood substitutes.
He subsequently spent two years as research fellow at the University of Minnesota Hospital working on endothelial cell signal transduction and responses to inflammatory and thrombotic mediators. His previous consultant positions have been as senior lecturer in the Chinese University of Hong Kong’s Department of Oncology, where he established the adult leukaemia service and high dose therapy with stem cell transplantation at the Prince of Wales Hospital from 1993 to 1997.
He then came to Australia, where he was senior consultant haematologist and head of research at The Queen Elizabeth Hospital’s department of haematology-oncology for two years. He moved to Townsville in 2000 to take up the position of director of haematology-oncology and chairman of the North Queensland Oncology Service until he returned to Adelaide in July 2003.
Dr Wickham has over 80 publications to his name, including several book chapters. He was appointed CEO of Clinpath Laboratories in October 2010, but continues to consult on a part-time basis at Adelaide Cancer Centre. He is also a visiting medical officer to Icon Cancer Care Adelaide.
Dr Wickham’s clinical interests are in benign and malignant haematological conditions in adults and his research interests include endothelial cell function and the role the endothelium plays in both metastasis and malignant coagulopathy.